AP News·3 min read·medium

New flu vaccine mFlusiva is approved for older people

L
Lauran Neergaard
New flu vaccine mFlusiva is approved for older people
AI Summary

The FDA has approved Moderna's new mRNA-based flu vaccine, mFlusiva, for adults aged 50 and older. This marks the first time mRNA technology, previously used for COVID-19, has been applied to a flu vaccine to potentially improve efficacy and manufacturing speed.

Add AP News as your preferred source to see more of our stories on Google. --> Share

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in